Marci Piasecki was promoted to regional director, North America, with oversight over all five US professional agencies in McCann Health, the most senior of a series of personnel moves the network said are designed to bolster the operation.
Roger Perlmutter has begun to trim the fat off Merck's lackluster pipeline.
Merck's proposed insomnia drug scores a thumbs-up from an FDA advisory panel, and long-time Forest Labs CEO Howard Solomon announces his coming retirement.
Dorothy Gemmell, who headed sales and sales operations at the portal, will take the reins at Havas Life New York.
Edelman nabs a GolinHarris exec, CMS submits Sunshine regs and McKesson expands its e-coupon reach.
Teva kicks off a succession plan early, and Merck launches Phase II trials of two all-oral hepatitis C regimens.
Amgen's former head of North America commercial operations joins Incyte, and pharma veteran James Sapirstein assumes the CEO position at Alliqua.
The American Medical Association has wooed New England Journal of Medicine publisher Tom Easley to Chicago, where he will preside over the society's publications, soon to be rolled up into the JAMA brand.
MM&M's 26th annual Career & Salary Survey is now open. Help us to give you the truest picture of salaries, opportunities, migration, aspirations and opinions within pharma and healthcare marketing.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.